Retatrutid

Produktübersicht

Retatrutide is classified as a multi-target synthetic peptide agonist within the category of pharmaceutical-grade research materials. This product is manufactured to meet stringent quality specifications established for biochemical research reagents and pharmaceutical raw materials.

Strukturelle Merkmale

From a structural perspective, Retatrutide is derived from GIP/GLP-1/Glucagon triple agonist. The primary structure comprises 39 amino acid residues with the sequence: 39 amino acids with fatty acid conjugation. The molecular formula is C218H342N54O67S with a calculated molecular weight of 4832.57 g/mol. The peptide adopts a linear acylated configuration. Distinguished structural features include: Tri-agonist activity, C20 fatty acid modification.

Manufacturing & Purification

Prüfung der Qualitätskontrolle

Storage & Handling

Forschung Anwendungen

Retatrutide is positioned within the pharmaceutical supply chain as a pharmaceutical-grade API intermediate suitable for in vitro investigational studies, assay development, analytical reference standard applications, and formulation development research. The product serves pharmaceutical research and development programs requiring characterized peptide materials with documented purity, identity, and quality specifications. Typical applications include receptor binding studies, structure-activity relationship investigations, analytical method development and validation, stability studies, and pharmaceutical formulation research. This compound is supplied exclusively for research purposes and as a pharmaceutical raw material to qualified institutions, academic laboratories, and licensed manufacturers operating under applicable regulatory frameworks. Distribution is restricted to organizations with appropriate handling capabilities and regulatory authorizations. Not intended for human or veterinary diagnostic or therapeutic use.

Typische Anwendungen sind: Rezeptorbindungsstudien, Untersuchungen der Struktur-Aktivitäts-Beziehung, Entwicklung von Analysemethoden, Stabilitätsstudien und pharmazeutische Formulierungsforschung.